
NGM Biopharmaceuticals NGM
Annual report 2023
added 03-11-2024
NGM Biopharmaceuticals Shares 2011-2026 | NGM
Annual Shares NGM Biopharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.5 M | 80 M | 77.1 M | 68.5 M | 50.3 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 82.5 M | 50.3 M | 71.7 M |
Quarterly Shares NGM Biopharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.7 M | 82.5 M | 82 M | 81.9 M | 80.6 M | 79.3 M | 78 M | 78 M | 77.4 M | 77.1 M | 76 M | 70.6 M | 68.8 M | 68.3 M | 67.4 M | 67 M | 65.9 M | 61 M | 6.81 M | 6.94 M | 6.53 M | 6.2 M | 6.13 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 82.7 M | 6.13 M | 59.9 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
38.7 M | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
4.73 M | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
220 M | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
1.55 B | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
4.28 M | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
9.34 B | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
98.5 M | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
54.9 B | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
21.6 M | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
22.6 M | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
68.9 M | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
66.6 M | - | - | $ 344 M | ||
|
IMV
IMV
|
8.34 M | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | ||
|
BioNTech SE
BNTX
|
242 M | $ 90.93 | 0.63 % | $ 22 B | ||
|
Autolus Therapeutics plc
AUTL
|
266 M | $ 1.65 | 1.85 % | $ 439 M | ||
|
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
2.19 M | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
93.4 M | $ 2.61 | -3.51 % | $ 244 M | ||
|
Anika Therapeutics
ANIK
|
14.3 M | $ 15.02 | -0.79 % | $ 215 M | ||
|
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
3.17 M | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
1.65 M | $ 3.44 | -0.58 % | $ 5.66 M | ||
|
AIkido Pharma
AIKI
|
14.3 M | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
2.45 M | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
117 M | $ 1.57 | 3.97 % | $ 184 M | ||
|
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
15.3 M | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
88.8 M | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
127 M | $ 21.01 | 2.64 % | $ 2.67 B | ||
|
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
25.4 M | - | 10.36 % | $ 9.8 M | ||
|
Applied Therapeutics
APLT
|
84.2 M | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
36.4 M | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
18.8 M | - | 17.91 % | $ 11.1 M |